Welcome to the e-CCO Library!

P739 Patients with Crohn’s disease with intestinal failure have less active disease than patients with Crohn’s disease without intestinal failure
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Bouri1, J. Willsmore2, J. Geldof1, S. Gabe2, S. Donnelly2, A. Hart1

Created: Thursday, 30 January 2020, 10:12 AM
P739: Characteristic of IBD related colorectal cancers observed in different Hungarian centers
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Rutka M.*1, Farkas K.2, Tiszlavicz L.3, Szepes Z.2, Balint A.2, Bor R.2, Fábián A.3, Milassin A.2, Miheller P.4, Banai J.5, Salamon A.6, Novák J.7, Vincze A.8, Lakatos L.9, Palatka K.10, Szamosi T.5, Kovács A.11, Gelley A.12, Nagy F.2, Molnar T.2

Created: Wednesday, 20 February 2019, 10:36 AM
P739: Early use of anti-TNF in Crohn’s disease is associated with higher rate of biological and endoscopic remission
Year: 2018
Source: ECCO '18 Vienna
Authors:

M.P. Costa Santos*, C. Gouveia, C. Palmela, C. Fidalgo, L. Glória, M. Cravo, J. Torres

Created: Thursday, 21 February 2019, 9:14 AM
P739: Sequential treatment is effective to achieve remission and avoid colectomy in moderate-to-severe Ulcerative Colitis refractory to anti-TNF therapy
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Farkas, B.(1)*;Borsos, M.(2);Resál, T.(1);Bacsur, P.(1);Bor, R.(1);Bálint, A.(1);Fábián, A.(1);Szepes, Z.(1);Molnár, T.(1);Farkas, K.(1);
Created: Friday, 14 July 2023, 11:12 AM
P739: The progression of inflammatory bowel disease throughout Latin America: a systematic review
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

P. Kotze*1, F. Underwood2, A. Damiao3, J. Ferraz2, R. Saad-Hossne4, M. Toro5, B. Iade6, F. Bosques-Padilla7, F. Teixeira8, F. Juliao-Baños9, D. Simian10, S. Ghosh11, R. Panaccione2, G. Kaplan2

Created: Friday, 22 February 2019, 9:41 AM
P740 Age determines the risk of familial IBD: A nationwide case–control study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J. Halfvarson1, J. Ludvigsson2, M. Sachs3, J. Askling3, O. Olén3

Created: Thursday, 30 January 2020, 10:12 AM
P740: Dual biologic therapy for patients with Inflammatory Bowel Disease in a single reference center in Spain
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Diz Lois Palomares, M.T.(1)*;Porta Sánchez, Á.(2);González Conde, B.(1);Estévez Prieto, E.(1);Vázquez Rey, M.T.(1);Elberdin Pazos, L.(2);Alonso Aguirre, P.(1);Martin Herranz, I.(2);
Created: Friday, 14 July 2023, 11:12 AM
P740: Efficacy and safety of vedolizumab in inflammatory bowel disease: Real-life experience
Year: 2018
Source: ECCO '18 Vienna
Authors:

C. González Muñoza1, F. Mesonero2, A. Bargalló3, A. Clos4, C. Aràjol5, J. Gordillo1*, A. López- San Román2, J. Guardiola5, M. Navarro-Llavat3, F. Bertoletti1, C. Fernández2, E. Domènech4,6, E. Garcia-Planella1

Created: Thursday, 21 February 2019, 9:14 AM
P740: Sexual quality of life in inflammatory bowel disease: a multi-centre, national-level study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Roseira*1, F. Magro2, S. Fernandes3, C. Simões3, F. Portela4, V. Ana Isabel5, M. Patita5, C. Leal6, P. Lago7, P. Caldeira8, T. Gago8, P. Currais9, A. Sampaio10, C. Dias2, H. Tavares de Sousa11, GEDII1

Created: Friday, 22 February 2019, 9:41 AM
P740: What kind of IBD patients succeed in smoking cessation? Insights from the Swiss IBD cohort study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Grueber M.*1, Allez M.2, Biedermann L.3, Clair Willi C.4, Fournier N.5, Schöpfer A.6, Vavricka S.7, Juillerat P.8, Macpherson A.J.9

Created: Wednesday, 20 February 2019, 10:36 AM
P741 Incidence and clinical phenotype of inflammatory bowel disease in the north–west of Spain (Vigo) between 1991 and 2011
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M.L. De Castro Parga1, V. De Castro Luisa Hernández2, J.R. Pineda2, J. Martinez Cadilla2, M. Figueira2, L. Sanromán2, S. Pereira2, J.I. Rodriguez-Prada2

Created: Thursday, 30 January 2020, 10:12 AM
P741: Do gastroenterology services need published standards for provision of antenatal care in patients with Inflammatory Bowel Disease? A local evaluation of UK practice.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Tolan, M.(1)*;Nartey, J.(1);Dattoo, M.(1);King, D.(1);de Silva, S.(1);
Created: Friday, 14 July 2023, 11:12 AM
P741: Fine-scale geographic distribution and ecological studies of Crohn’s disease in France (2007–2014)
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Genin*1, M. Fumery2, F. Occelli3, G. Savoye4, B. Pariente5, L. Dauchet6, C. Vignal7, M. Body-Malapel7, J. Giovannelli8, H. Sarter9, C. Gower-Rousseau8, G. Ficheur10

Created: Friday, 22 February 2019, 9:41 AM
P741: IBD-related work disability in Brazil
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Froes R.*1, Carvalho A.T.1, Carneiro A.J.2, Moreira A.3, Moreira J.4, Luiz R.4, de Souza H.2

Created: Wednesday, 20 February 2019, 10:36 AM
P741: Very high rate of tuberculosis complicating infliximab therapy for inflammatory bowel disease despite tuberculosis screening in India
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Agarwal*, S. Kedia, S. Jain, V. Gupta, S. Bopanna, D. Yadav, S. Goyal, P.M. Venegella, G. Makharia, V. Ahuja

Created: Thursday, 21 February 2019, 9:14 AM
P742 Morbidity and mortality outcomes of paediatric-onset inflammatory bowel disease in early adult life: A Scottish population-based, nested case–control study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

C. Burgess1,2, C. Schnier3, I. Chalmers4, R.K. Russell5, R. Hansen5, P. Henderson1,2, R. Wood6,7, D.C. Wilson1,2

Created: Thursday, 30 January 2020, 10:12 AM
P742: Arterial stiffness as a marker of vascular aging in IBD patients – a pilot study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Prijic R.*1, Premuzic V.2, Jelakovic M.1, Kunovic A.3, Grgic D.1, Brinar M.1,4, Turk N.1, Krznaric Z.1,3,4, Vucelic B.1,4, Cukovic-Cavka S.1,4

Created: Wednesday, 20 February 2019, 10:36 AM
P742: Iranian Registry of Crohn’s and Colitis (IRCC): first nation-wide IBD registry in Middle East, a study protocol
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Malekzadeh1, A. Sima2, S. Alatab2, A. Sadeghi2, N. Ebrahimi Daryani3, P. Adibi4, I. Maleki5, H. Vossoughinia6, H. Fakheri5, A. Yazdanbod7, S. A. Taghavi8, R. Aghazadeh9, M. H. Somi10, K. Zendehdel11,12, H. Vahedi1, R. Malekzadeh*1

Created: Friday, 22 February 2019, 9:41 AM
P742: Long-term outcome of patients with ulcerative colitis and first course of intravenous corticosteroids
Year: 2018
Source: ECCO '18 Vienna
Authors:

H. Eronen1*, P. Oksanen1,2, A. Jussila1

Created: Thursday, 21 February 2019, 9:14 AM
P742: Real-world evidence comparison on the effectiveness of ustekinumab vs anti-TNF or vedolizumab in ulcerative colitis: induction phase results from the prospective, observational RUN-UC study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Bokemeyer, B.(1,2,3)*;Plachta-Danielzek, S.(2);Howaldt, S.(4);Mohl, W.(5);Efken, P.(6);Ehehalt, R.(7);Kahl, M.(8);Krause, T.(9);Trentmann, L.(10);Lügering, A.(11);Schnoy, E.(12);Jochum, C.(13);Fajardo Salmon, S.(2);Hartmann, P.(6);Gilman, E.(2);Schreiber, S.(2,3);
Created: Friday, 14 July 2023, 11:12 AM